Olfactory system pathology as a model of Lewy neurodegenerative disease

Hawkes, 1997, Olfactory dysfunction in Parkinson's disease, J Neurol Neurosurg Psychiatry, 62, 436, 10.1136/jnnp.62.5.436 Doty, 1988, Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration, Neurology, 38, 1237, 10.1212/WNL.38.8.1237 Hower, 2008, Olfactory dysfunction and Parkinson's disease progression, Neurology, 70, A397 Kratskin, 2003, Anatomy and neurochemistry of the olfactory bulb, 235 Shepherd, 1997, Olfactory bulb, 159 Duda, 1999, The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases, Exp Neurol, 160, 515, 10.1006/exnr.1999.7228 Daniel, 1992, Preliminary diagnosis of Parkinson's disease by olfactory bulb pathology, Lancet, 340, 186, 10.1016/0140-6736(92)93275-R Polymeropoulos, 1997, Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science, 276, 2045, 10.1126/science.276.5321.2045 Spillantini, 1997, Alpha-synuclein in Lewy bodies, Nature, 388, 839, 10.1038/42166 Spillantini, 1998, Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies, Proc Natl Acad Sci U S A, 95, 6469, 10.1073/pnas.95.11.6469 Beach, 2009, Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders, Acta Neuropathol, 117, 169, 10.1007/s00401-008-0450-7 Tsuboi, 2003, Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4, Neuropathol Appl Neurobiol, 29, 503, 10.1046/j.1365-2990.2003.00453.x Duda, 2002, Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred, Acta Neuropathol (Berl), 104, 7, 10.1007/s00401-002-0563-3 Frasier, 2004, Following the leader: fibrillization of alpha-synuclein and tau, Exp Neurol, 187, 235, 10.1016/j.expneurol.2004.02.008 Lee, 2004, More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases, Trends Neurosci, 27, 129, 10.1016/j.tins.2004.01.007 Braak, 2002, Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages), J Neurol, 249, III/1, 10.1007/s00415-002-1301-4 Braak, 2003, Staging of brain pathology related to sporadic Parkinson's disease, Neurobiol Aging, 24, 197, 10.1016/S0197-4580(02)00065-9 Lerner, 2008, Olfactory pathogenesis of idiopathic Parkinson disease revisited, Mov Disord, 23, 1076, 10.1002/mds.22066 Hawkes, 2007, Parkinson's disease: a dual-hit hypothesis, Neuropathol Appl Neurobiol, 33, 599, 10.1111/j.1365-2990.2007.00874.x Pearce, 1995, The anterior olfactory nucleus in Parkinson's disease, Mov Disord, 10, 283, 10.1002/mds.870100309 Silveira-Moriyama, 2009, Regional differences in the severity of Lewy body pathology across the olfactory cortex, Neurosic Lett, 453, 77, 10.1016/j.neulet.2009.02.006 Hoogland, 2003, Misrouted olfactory fibres and ectopic olfactory glomeruli in normal humans and in Parkinson and Alzheimer patients, Neuropathol Appl Neurobiol, 29, 303, 10.1046/j.1365-2990.2003.00459.x Huisman, 2004, A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease, Mov Disord, 19, 687, 10.1002/mds.10713 Huisman, 2008, Gender-related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson's disease patients, Mov Disord, 23, 1407, 10.1002/mds.22009 Smeets, 2000, Catecholamine systems in the brain of vertebrates: new perspectives through a comparative approach, Brain Res Brain Res Rev, 33, 308, 10.1016/S0165-0173(00)00034-5 Van Den Eeden, 2003, Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity, Am J Epidemiol, 157, 1015, 10.1093/aje/kwg068 Shulman, 2007, Gender differences in Parkinson's disease, Gend Med, 4, 8, 10.1016/S1550-8579(07)80003-9 Bedard, 2004, Evidence of newly generated neurons in the human olfactory bulb, Brain Res Dev Brain Res, 151, 159, 10.1016/j.devbrainres.2004.03.021 Liu, 2003, Olfactory bulb core is a rich source of neural progenitor and stem cells in adult rodent and human, J Comp Neurol, 459, 368, 10.1002/cne.10664 Höglinger, 2004, Dopamine depletion impairs precursor cell proliferation in Parkinson disease, Nat Neurosci, 7, 726, 10.1038/nn1265 Doty, 1993, Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease, Neurology, 43, 962, 10.1212/WNL.43.5.962 Wenning, 1995, Olfactory function in atypical parkinsonian syndromes, Acta Neurol Scand, 91, 247, 10.1111/j.1600-0404.1995.tb06998.x Busenbark, 1992, Olfactory function in essential tremor, Neurology, 42, 1631, 10.1212/WNL.42.8.1631 Louis, 2002, Olfactory dysfunction in essential tremor: a deficit unrelated to disease duration or severity, Neurology, 59, 1631, 10.1212/01.WNL.0000033798.85208.F2 Doty, 1992, Lack of major olfactory dysfunction in MPTP-induced parkinsonism, Ann Neurol, 32, 97, 10.1002/ana.410320116 Stern, 1994, Olfactory function in Parkinson's disease subtypes, Neurology, 44, 266, 10.1212/WNL.44.2.266 Ondo, 2005, Olfaction testing in patients with tremor-dominant Parkinson's disease: is this a distinct condition?, Mov Disord, 20, 471, 10.1002/mds.20365 Duda, 2004, Pathology and neurotransmitter abnormalities of dementia with Lewy bodies, Dement Geriatr Cogn Disord, 17, 3, 10.1159/000074677 Duda, 2003, Is the initial insult in Parkinson's disease and dementia with Lewy bodies a neuritic dystrophy?, Ann NY Acad Sci, 991, 295, 10.1111/j.1749-6632.2003.tb07488.x Braak, 2003, Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen, J Neural Transm, 110, 517, 10.1007/s00702-002-0808-2 Duda, 2002, Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases, Ann Neurol, 52, 205, 10.1002/ana.10279